製薬業界の動向と新しい技術に関するインサイト
合計59件の記事

The reported inclisiran architecture illustrates why an siRNA conjugate cannot be reduced to a sequence plus a targeting ligand. Descriptions of that architecture place a triantennary N-acetylgalactosamine (GalNAc) unit at the sense-strand terminus, combine 2'-fluoro and 2'-O-methyl ribose substitutions with terminal phosphorothioate linkages, and rely on the antisense strand for RNA-induced silencing complex (RISC) loading. Each element addresses a different constraint: cell uptake, nuclease exposure, strand handling, or intracellular recognition.

Crossref metadata verifies the primary paper's title, authorship, journal, DOI, and publication record. The detailed construct is reported as combining an Fe(CO)3 CO-releasing molecule, a Val-Cit-PABC trigger, and thiol conjugation to trastuzumab after interchain disulfide reduction.

The siRNA guide-strand 5′-phosphate is a recognition element for engagement with the AGO2 MID domain. The preprint examines a different way to modify that terminus: installing an organic substituent on a nonbridging phosphate oxygen while retaining a phosphate-centered anchoring group.

Pyrrolobenzodiazepine (PBD) dimers join two PBD units to create a bifunctional DNA-reactive scaffold. For ADC development, the useful question is not which free payload appears most potent in an isolated assay. It is how electrophile state, linker architecture, hydrophilicity, conjugation level, release behavior, and analytical control work together in the complete linker–payload and conjugate.

Fatty-acid-derived modification can introduce an albumin-binding handle, but the chain alone does not define the conjugate. Functional group identity, linker composition, attachment position, and the peptide sequence all influence what must be synthesized, purified, and measured.

The paper describes a de novo workflow built around four structural fragments: two are positioned at selected regions of a protein surface, and two are used to connect the docked segments into a closed backbone. Candidate scaffolds then move through geometry-based ranking, fixed-backbone sequence redesign, and molecular-dynamics-based prioritization.